Based on the current situation of the insufficiency of current therapies, this study focuses on analyzing the biological function of LOXL2 in the occurrence and development of glioma by bioinformatics technology, and systematically evaluates the potential association between this molecular marker and the prognosis of patients. This evidence concerns the gene LOXL2 and central nervous system cancer.